![Richard Wagner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Wagner
Amministratore Delegato presso Bonito Biosciences
Patrimonio netto: - $ in data 31/05/2024
Profilo
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts) founded in 2009, Zebiai Therapeutics, Inc. founded in 2019, and Bonito Biosciences founded in 2022, where he held the title of Chief Executive Officer.
He also held the position of Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. and served as an Independent Director at Eterna Therapeutics, Inc. for the year 2023.
Dr. Wagner holds a doctorate degree from Brown University and an undergraduate degree from Trinity College (Connecticut).
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 13/07/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Richard Wagner
Società | Posizione | Inizio |
---|---|---|
Bonito Biosciences | Amministratore Delegato | 01/06/2022 |
Precedenti posizioni note di Richard Wagner
Società | Posizione | Fine |
---|---|---|
ETERNA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 08/08/2023 |
X-Chem, Inc. (Massachusetts)
![]() X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Amministratore Delegato | 03/06/2020 |
Zebiai Therapeutics, Inc.
![]() Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Amministratore Delegato | - |
Praecis Pharmaceuticals, Inc.
![]() Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Richard Wagner
Brown University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ETERNA THERAPEUTICS INC. | Health Technology |
Aziende private | 4 |
---|---|
Praecis Pharmaceuticals, Inc.
![]() Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
X-Chem, Inc. (Massachusetts)
![]() X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
Zebiai Therapeutics, Inc.
![]() Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
Bonito Biosciences |
- Borsa valori
- Insiders
- Richard Wagner